Trialbee Honey™ Adds New Features
Latest enhancements will optimize Omnichannel capabilities for ROI reporting.
Trialbee has enhanced its Omnichannel recruitment strategy by adding features for transparency into performance across all channels, sources, and recruitment partners.
Available in the Trialbee Honey™ platform, these vendor-agnostic insights provide real-time ROI data, With Honey Omnichannel, customers can:
- Understand the current status, progress, and trajectory of their enrollment milestones.
- Objectively evaluate partner performance including third-party recruitment providers, CROs, patient advocacy groups, and more.
- Dive deep into the relative value of specific social channels (e.g., Facebook, Instagram, TikTok), digital mediums (email, social, programmatic), and individual campaigns by each referrer in their recruitment ecosystem.
By aggregating and analyzing all referrer channels into a single funnel with visual dashboards and insightful analytics, Trialbee Honey™ enables enrollment outcomes through stronger candidate sourcing.
Reference
Trialbee Honey™ Adds New Features to Optimize Omnichannel Capabilities for ROI Reporting Across All Patient Recruitment Sources and Vendors. (2023, May 17). Cision PRWeb.
Phase III Trial Finds Baricitinib Boosts Hair Regrowth in Adolescents With Severe Alopecia Areata
March 14th 2025The BRAVE-AA-PEDS trial found that once-daily baricitinib significantly improved hair regrowth on the scalp, eyebrows, and eyelashes in adolescents with severe alopecia areata after 36 weeks, with faster response rates compared to adults.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
